C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/06 (2006.01) C12P 21/04 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2571250
Human GALNT genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of GALNT are provided.
Des gènes GALNT humains sont identifiés comme modulateurs du chemin IGFR, et sont ainsi des cibles thérapeutiques pour des troubles associés à une fonction IGFR défectueuse. La présente invention concerne donc des procédés permettant d'identifier des modulateurs d'IGFR, avec recherche par criblage d'agents modulant l'activité de GALNT.
Bjerke Lynn Margaret
Francis-Lang Helen
Friedman Lori S.
Heuer Timothy S.
Parks Annette L.
Bennett Jones Llp
Exelixis Inc.
LandOfFree
Galnts as modifiers of the igfr pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galnts as modifiers of the igfr pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galnts as modifiers of the igfr pathway and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1835568